Martin B. Edelshain
Keine laufenden Positionen mehr
Profil
Martin B.
Edelshain joined Gen-Probe, Inc. in November 2003 as Vice President of Corporate Development and has been Senior Vice President-Corporate Strategy since May 2007.
He was a Business Consultant of Gen-Probe.
Mr. Edelshain was Director of International Strategy of Chugai Pharmaceutical Co. Ltd.
from 1995 to 2002.
He worked in the corporate finance of S.
G.
Warburg & Co. Ltd.
from 1970 to 1995.
Mr. Edelshain received a BA degree in Mechanical Sciences from Cambridge University.
Ehemalige bekannte Positionen von Martin B. Edelshain
| Unternehmen | Position | Ende |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | 01.01.2002 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Martin B. Edelshain
| University of Cambridge | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
